MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,630,262 | -20.0% | 24,858 | +26.6% | 0.00% | -25.0% |
| Q2 2023 | $4,536,147 | +44.7% | 19,637 | +51.8% | 0.00% | +33.3% |
| Q1 2023 | $3,134,360 | +49.7% | 12,938 | -27.7% | 0.00% | +50.0% |
| Q1 2021 | $2,094,000 | +5.2% | 17,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,990,000 | -8.4% | 17,900 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $2,173,000 | +8.4% | 18,300 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $2,005,000 | +84.3% | 17,700 | +8.6% | 0.00% | +100.0% |
| Q1 2020 | $1,088,000 | -27.6% | 16,300 | -1.2% | 0.00% | 0.0% |
| Q4 2019 | $1,503,000 | +24.5% | 16,500 | +17.9% | 0.00% | 0.0% |
| Q3 2019 | $1,207,000 | +84.6% | 14,000 | +124.4% | 0.00% | 0.0% |
| Q2 2019 | $654,000 | -4.0% | 6,238 | +14.7% | 0.00% | 0.0% |
| Q1 2019 | $681,000 | +9.1% | 5,438 | -1.8% | 0.00% | 0.0% |
| Q4 2018 | $624,000 | -72.8% | 5,538 | -48.3% | 0.00% | -66.7% |
| Q3 2018 | $2,295,000 | +38.9% | 10,718 | +81.4% | 0.00% | +50.0% |
| Q2 2018 | $1,652,000 | +265.5% | 5,908 | +52.7% | 0.00% | +100.0% |
| Q1 2018 | $452,000 | – | 3,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 199,500 | $55,798,000 | 5.31% |
| Avoro Capital Advisors LLC | 489,536 | $136,918,000 | 5.27% |
| Rock Springs Capital Management LP | 342,300 | $95,738,000 | 3.68% |
| Boxer Capital, LLC | 95,000 | $26,571,000 | 3.01% |
| Baker Brothers Advisors | 1,169,278 | $327,035,000 | 2.46% |
| Vivo Capital, LLC | 62,220 | $17,402,000 | 2.24% |
| SHIKIAR ASSET MANAGEMENT INC | 17,541 | $4,906,000 | 2.05% |
| Ghost Tree Capital, LLC | 23,500 | $6,573,000 | 1.93% |
| HealthCor Management, L.P. | 197,281 | $55,178,000 | 1.75% |
| ACUTA CAPITAL PARTNERS, LLC | 34,803 | $9,734,000 | 1.73% |